Structural Heart Devices Market to Reach USD 30.62 Billion by 2034 at 10.08% CAGR | DelveInsight

DelveInsight's "Structural Heart Devices Market Insights, Epidemiology, and Market Forecast" report delivers an in-depth understanding of the Structural Heart Devices market, covering product type, application, end-user, and geography across North America, Europe, Asia-Pacific, and Rest of World.

Explore the intricate details of the Structural Heart Devices Market Report @ https://www.delveinsight.com/report-store/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Key Takeaways from Structural Heart Devices Market Report
• In May 2026, Artivion, Inc., the parent company of JOTEC GmbH, completed its acquisition of Endospan Ltd. for an upfront net purchase price of USD 135 million, adding the NEXUS Aortic Arch System to its portfolio.
• In February 2026, Valcare Medical, Inc., announced the successful first U.S. transseptal implantation of its AMEND Transcatheter Mitral Valve Repair Annuloplasty System.
• In January 2026, XELTIS BV published early clinical outcomes from two trials of its restorative pulmonary valve conduit.
• The Structural Heart Devices market is estimated at USD 12.94 billion in 2025 and is projected to reach USD 30.62 billion by 2034, growing at a CAGR of 10.08% from 2026 to 2034.
• By product type, the replacement device segment dominated the market with a 63% share in 2025.
• By application, the atrial septal defect segment dominated the market with a 29% share in 2025.
• By end-user, the hospital segment dominated the market with a 45% share in 2025.
• North America dominated the global market revenue with a 50% share in 2025, the highest regional share globally, while Asia-Pacific is the fastest-growing region.
• The Structural Heart Devices market is classified as Moderately Consolidated, led by Medtronic, Edwards Lifesciences, Abbott, and Boston Scientific.

Get a Free sample for the Structural Heart Devices Market Forecast, Size & Share Analysis Report @ https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

What are Structural Heart Devices?
A structural heart device is a specialized medical technology designed to diagnose, repair, or replace abnormalities in the heart's structure, including its valves, chambers, walls, and associated vessels. Structural heart disease encompasses both congenital defects, such as atrial septal defect, ventricular septal defect, and patent foramen ovale, and acquired valvular disorders, such as aortic valve stenosis and mitral regurgitation. Treatment increasingly relies on catheter-based repair devices, including occluders, annuloplasty devices, and valvuloplasty devices, alongside surgical and transcatheter replacement devices, including mechanical and tissue heart valves. These technologies offer minimally invasive alternatives to open-heart surgery, reducing surgical trauma, shortening hospital stays, and expanding treatment access to elderly and high-risk patients who are often poor candidates for conventional surgery.

Structural Heart Devices Market Segmentation
• By Product Type: Repair Device (Occluders, Annuloplasty Devices, Valvuloplasty Devices, and Others) and Replacement Device (Mechanical Heart Valves and Tissue Heart Valves)
• By Application: Atrial Septal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, and Others
• By End-User: Hospital, Ambulatory Surgical Centers, and Others
• By Geography: North America, Europe, Asia-Pacific, and Rest of World

Download the report to understand which factors are driving Structural Heart Devices market trends @ https://www.delveinsight.com/report-store/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Structural Heart Devices Market Key Growth Drivers
• Rising Prevalence of Cardiovascular and Valvular Disorders: Aortic valve stenosis affects an estimated 9 million people worldwide, and mitral regurgitation affects nearly 24 million people globally. Congenital heart defects affect nearly 1% of all births in the United States, roughly 40,000 babies each year, and more than 5 million Americans are diagnosed with heart valve disease annually, with over 25,000 associated deaths.
• Technological Advancements in Transcatheter Platforms: Next-generation transcatheter heart valves, minimally invasive mitral and tricuspid repair systems, and AI-enabled procedural guidance are broadening eligible patient anatomies, including bicuspid valves, and improving procedural outcomes.
• Growing Demand for Minimally Invasive Cardiac Interventions: Catheter-based procedures offer reduced surgical trauma, shorter hospital stays, and faster recovery relative to open-heart surgery, with TAVR now standard care across high-risk and intermediate-risk patient groups.
• Regulatory Approvals and Expanding Clinical Indications: Edwards Lifesciences' SAPIEN M3 transcatheter mitral valve replacement system received CE Mark approval in April 2025, and Abbott reported two-year TRILUMINATE Pivotal trial results for its TriClip system in March 2025.
• Investment, M&A Activity, and Portfolio Expansion: Boston Scientific acquired Baylis Medical, and Artivion completed its USD 135 million acquisition of Endospan Ltd. in May 2026 to expand its aortic arch and structural repair platform.
• Aging Population and Rising Cardiovascular Risk Factors: In the United Kingdom, heart valve disease affects 11.29% of individuals aged 65 and older, while in Australia, more than 500,000 individuals were diagnosed with heart valve disease in 2024, with an additional estimated 250,000 cases undiagnosed.

Structural Heart Devices Market Restraints
Frequent product failures and recalls undermine physician confidence and disrupt treatment adoption. Stringent regulatory requirements, including extensive clinical trials and long evaluation timelines, slow innovation and create barriers to entry. High capital intensity for developing and manufacturing transcatheter platforms, alongside the need for specialized hybrid operating rooms and catheterization labs, constrains adoption in emerging economies. Reimbursement variability and tariffs on imported medical devices further temper near-term growth.

Structural Heart Devices Market Companies
Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, and others

Structural Heart Devices Market Outlook
The market is anchored by the rising global burden of valvular and structural heart disease, rapid adoption of transcatheter repair and replacement technologies, and continued expansion of minimally invasive interventional cardiology infrastructure. North America is expected to retain its lead through 2034, supported by strong reimbursement frameworks and regulatory clarity, while Asia-Pacific is projected to be the fastest-growing region, driven by rising disease prevalence and expanding interventional cardiology infrastructure across China, Japan, India, South Korea, and Australia.

Scope of the Structural Heart Devices Market Report
• Study Period: Market estimated in 2025, forecast through 2034
• Coverage: North America, Europe, Asia-Pacific, and Rest of World
• Structural Heart Devices Companies: Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, and others
• Structural Heart Devices Market Segmentation: By Product Type, Application, End-User, and Geography
• Structural Heart Devices Market Dynamics: Market drivers and market restraints
• Competitive Landscape: Market concentration, leading players, geographic reach, clinical evidence, strategic partnerships, M&A activity, manufacturing capabilities, and innovation focus

To know more about Structural Heart Devices companies working in the market, visit @ https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Table of Content
1. Structural Heart Devices Market Report Introduction
2. Structural Heart Devices Market Executive Summary
3. Structural Heart Devices Market Key Factors Analysis
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
6. Structural Heart Devices Market Porter's Five Forces Analysis
7. Structural Heart Devices Market Assessment
8. Structural Heart Devices Market Competitive Landscape
9. Structural Heart Devices Market Startup Funding and Investment Trends
10. Structural Heart Devices Market Company and Product Profiles
11. KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer and Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com

About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.